The efficiency of β-cyclodextrin in the post-dyeing removal of hydrolyzed reactive dyes

Reaktivna bojila su skupina bojila koja se najviše upotrebljavaju za bojadisanje celuloznih vlakana. Tijekom postupka bojadisanja ovim bojilima, hidroliza bojila može uzrokovati smanjenje učinkovitosti bojadisanja i otežano ispiranje bojila nakon bojadisanja. Uklanjanje hidroliziranog bojila s materijala postupkom ispiranja je vrlo važno kako bi se postigla dobra svojstva postojanosti obojenja. U ovom radu istraživana je primjena β-ciklodekstrina, nano-tvari sastavljene od 7 D-glukopiranozil jedinica povezanih alfa-(1,4) glikozidnim vezama, čime se pospješuje ispiranje hidroliziranog bojila nakon provedbe bojadisanja. Prema dobivenim rezultatima može se reći da je moguća primjena β-ciklodekstrina u ispiranju nakon bojadisanja reaktivnim bojilima za bojila koja s njima stvaraju (inclusion) komplekse.Reactive dyes are the most commonly used dye class in cellulosic fibers dyeing. But during dyeing with these dyes, the hydrolyzation of dye may decrease dyeing efficiency and may cause the washing treatments after dyeing to be much harder. It is very important to remove hydrolyzed reactive dye from the textile material by washing treatments to obtain the desired fastness properties. In this research, usage possibilities of β-cyclodextrins, that are nano-substances structurally consist of 7 D-glucopyranosyl units connected by alpha-(1,4) glycosidic linkages, to enhance hydrolyzed reactive dye in washing treatments after reactive dyeing were investigated. According to the experimental results, it can be said that usage of β-cyclodextrins is possible in washing treatments after reactive dyeing for dyes which form inclusion complex with it

The efficiency of β-cyclodextrin in the post-dyeing removal of hydrolyzed reactive dyes

Reaktivna bojila su skupina bojila koja se najviše upotrebljavaju za bojadisanje celuloznih vlakana. Tijekom postupka bojadisanja ovim bojilima, hidroliza bojila može uzrokovati smanjenje učinkovitosti bojadisanja i otežano ispiranje bojila nakon bojadisanja. Uklanjanje hidroliziranog bojila s materijala postupkom ispiranja je vrlo važno kako bi se postigla dobra svojstva postojanosti obojenja. U ovom radu istraživana je primjena β-ciklodekstrina, nano-tvari sastavljene od 7 D-glukopiranozil jedinica povezanih alfa-(1,4) glikozidnim vezama, čime se pospješuje ispiranje hidroliziranog bojila nakon provedbe bojadisanja. Prema dobivenim rezultatima može se reći da je moguća primjena β-ciklodekstrina u ispiranju nakon bojadisanja reaktivnim bojilima za bojila koja s njima stvaraju (inclusion) komplekse.Reactive dyes are the most commonly used dye class in cellulosic fibers dyeing. But during dyeing with these dyes, the hydrolyzation of dye may decrease dyeing efficiency and may cause the washing treatments after dyeing to be much harder. It is very important to remove hydrolyzed reactive dye from the textile material by washing treatments to obtain the desired fastness properties. In this research, usage possibilities of β-cyclodextrins, that are nano-substances structurally consist of 7 D-glucopyranosyl units connected by alpha-(1,4) glycosidic linkages, to enhance hydrolyzed reactive dye in washing treatments after reactive dyeing were investigated. According to the experimental results, it can be said that usage of β-cyclodextrins is possible in washing treatments after reactive dyeing for dyes which form inclusion complex with it

Academic Performance and Behavioral Patterns

Identifying the factors that influence academic performance is an essential part of educational research. Previous studies have documented the importance of personality traits, class attendance, and social network structure. Because most of these analyses were based on a single behavioral aspect and/or small sample sizes, there is currently no quantification of the interplay of these factors. Here, we study the academic performance among a cohort of 538 undergraduate students forming a single, densely connected social network. Our work is based on data collected using smartphones, which the students used as their primary phones for two years. The availability of multi-channel data from a single population allows us to directly compare the explanatory power of individual and social characteristics. We find that the most informative indicators of performance are based on social ties and that network indicators result in better model performance than individual characteristics (including both personality and class attendance). We confirm earlier findings that class attendance is the most important predictor among individual characteristics. Finally, our results suggest the presence of strong homophily and/or peer effects among university students

Left ventricular apical diseases

There are many disorders that may involve the left ventricular (LV) apex; however, they are sometimes difficult to differentiate. In this setting cardiac imaging methods can provide the clue to obtaining the diagnosis. The purpose of this review is to illustrate the spectrum of diseases that most frequently affect the apex of the LV including Tako-Tsubo cardiomyopathy, LV aneurysms and pseudoaneurysms, apical diverticula, apical ventricular remodelling, apical hypertrophic cardiomyopathy, LV non-compaction, arrhythmogenic right ventricular dysplasia with LV involvement and LV false tendons, with an emphasis on the diagnostic criteria and imaging features

Clinical presentations and diagnostic work-up in sarcoidosis: A series of Turkish cases (clinics and diagnosis of sarcoidosis)

Sarcoidosis is an idiopathic granulomatous disease. It usually affects the lung. The diagnosis may be problematic since the known causes of granulomatous inflammation must be excluded. This multicenter study aimed to evaluate the clinical presentations and diagnostic approaches of sarcoidosis. The study protocol was sent via internet, and the participants were asked to send the information (clinical, radiological and diagnostic) on newly diagnosed sarcoidosis cases. 293 patients were enrolled within two years. Pulmonary symptoms were found in 73.3% of the patients, and cough was the most common one (53.2%), followed by dyspnea (40.3%). Constitutional symptoms were occured in half of the patients. The most common one was fatigue (38.6%). The most common physical sign was eritema nodosum (17.1%). The most common chest radiograhical sign was bilateral hilar lymphadenomegaly (78.8%). Staging according to chest X-ray has revealed that most of the patients were in Stage I and Stage II (51.9% and 31.7%, respectively). Sarcoidosis was confirmed histopathologically in 265 (90.4%) patients. Although one-third of the bronchoscopy was revealed normal, mucosal hyperemi (19.8%) and external compression of the bronchial wall (16.8%) were common abnormal findings. The 100% success rate was obtained in mediastinoscopy among the frequently used sampling methods. Transbronchial biopsy was the most frequently used method with 48.8% success rate. Considering sarcoidosis with its most common and also rare findings in the differential diagnosis, organizing the related procedures according to the possibly effected areas, and the expertise of the team would favor multimodality diagnosis

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study

We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among a large group of physicians and compared their diagnostic performance to a panel of IPF experts. A total of 1141 respiratory physicians and 34 IPF experts participated. Participants evaluated 60 cases of interstitial lung disease (ILD) without interdisciplinary consultation. Diagnostic agreement was measured using the weighted kappa coefficient (\u3baw). Prognostic discrimination between IPF and other ILDs was used to validate diagnostic accuracy for first-choice diagnoses of IPF and were compared using the Cindex. A total of 404 physicians completed the study. Agreement for IPF diagnosis was higher among expert physicians (\u3baw=0.65, IQR 0.53-0.72, p20 years of experience (C-index=0.72, IQR 0.0-0.73, p=0.229) and non-university hospital physicians with more than 20 years of experience, attending weekly MDT meetings (C-index=0.72, IQR 0.70-0.72, p=0.052), did not differ significantly (p=0.229 and p=0.052 respectively) from the expert panel (C-index=0.74 IQR 0.72-0.75). Experienced respiratory physicians at university-based institutions diagnose IPF with similar prognostic accuracy to IPF experts. Regular MDT meeting attendance improves the prognostic accuracy of experienced non-university practitioners to levels achieved by IPF experts

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049